Meniscal Insert - Ultracongruent - Prosthesis, knee, internal, insert component

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Buy It Now

Available from:

Allegra Orthopaedics Limited

Class:

Class III

Manufactured by:

Allegra Orthopaedics Limited Unit 2 / 12 Frederick Street, ST LEONARDS, NSW, 2065 Australia

Therapeutic area:

46585 - Prosthesis, knee, internal, insert component

Therapeutic indications:

A polyethylene liner component designed to provide the articulating bearing surface between the femoral and tibial components of a total knee replacement. The Ultracongruent is designed with an anterior lip for additional posterior stability. The meniscal ultracongruent insert implant is a component of the Active Knee System. The patient should be skeletally mature to receive a knee replacement. Patients should have adequate bone stock and size to support prosthesis. It is intended for Non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, or avascular necrosis; Inflammatory degenerative joint disease including rheumatoid arthritis; Functional deformity such as varus, valgus or flexion deformities; Revision procedures where other treatments or devices have failed; Fractures that are unmanageable using other techniques.

Authorization status:

A

Authorization date:

2013-11-14

Search alerts related to this product